Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 3, 2026

Study Completion Date

September 1, 2026

Conditions
Acute Chest Syndrome
Interventions
PROCEDURE

Red blood cell EXchange (REX)

A single automated REX will be performed, as soon as possible after randomization.

Trial Locations (1)

94010

Armand MEKONTSO DESSAP, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06214845 - Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease | Biotech Hunter | Biotech Hunter